Early successful reperfusion after endovascular therapy reduces malignant middle cerebral artery infarction occurrence in young patients with large diffusion-weighted imaging lesions.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
10 2020
Historique:
received: 29 04 2020
accepted: 08 05 2020
pubmed: 21 5 2020
medline: 7 7 2021
entrez: 21 5 2020
Statut: ppublish

Résumé

Malignant middle cerebral artery infarction (MMI) is a severe complication of acute ischaemic stroke (AIS). The aim of our study was to assess whether successful reperfusion after endovascular therapy (EVT) in AIS with clinical and imaging predictors of MMI decreased its occurrence. Data were collected between January 2014 and July 2018 in a monocentric prospective AIS registry of patients treated with EVT. Patients selected were <65 years old with severe anterior circulation AIS with a National Institutes of Health Stroke Scale score >15, baseline Diffusion-Weighted Imaging-Alberta Stroke Program Early Computed Tomography Score ≤ 6 and baseline diffusion-weighted imaging lesion volume >82 mL within 6 h of symptom onset. Successful reperfusion was defined as a Thrombolysis in Cerebral Ischemia score ≥ 2b. Occurrence of MMI was the primary endpoint. A total of 66 EVT-treated patients were included in our study. MMI occurred in 27 patients (41%). In unadjusted analysis, successful reperfusion was associated with fewer MMIs (31.8% vs. 65.0%; P = 0.015) and with more favorable outcome at 3 months (50% vs. 20%; P = 0.023). In multivariate analysis, successful reperfusion was associated with an adjusted odds ratio (95% confidence intervals) of 0.35 (0.10-1.12) for MMI and 2.77 (0.84-10.43) for 3-month favorable outcome occurrence. Early successful reperfusion performed in patients with AIS with clinical and imaging predictors of MMI was associated with decreased MMI occurrence. Reperfusion status might be considered in evaluating the need for craniectomy in patients with early predictors of MMI.

Sections du résumé

BACKGROUND AND PURPOSE
Malignant middle cerebral artery infarction (MMI) is a severe complication of acute ischaemic stroke (AIS). The aim of our study was to assess whether successful reperfusion after endovascular therapy (EVT) in AIS with clinical and imaging predictors of MMI decreased its occurrence.
METHODS
Data were collected between January 2014 and July 2018 in a monocentric prospective AIS registry of patients treated with EVT. Patients selected were <65 years old with severe anterior circulation AIS with a National Institutes of Health Stroke Scale score >15, baseline Diffusion-Weighted Imaging-Alberta Stroke Program Early Computed Tomography Score ≤ 6 and baseline diffusion-weighted imaging lesion volume >82 mL within 6 h of symptom onset. Successful reperfusion was defined as a Thrombolysis in Cerebral Ischemia score ≥ 2b. Occurrence of MMI was the primary endpoint.
RESULTS
A total of 66 EVT-treated patients were included in our study. MMI occurred in 27 patients (41%). In unadjusted analysis, successful reperfusion was associated with fewer MMIs (31.8% vs. 65.0%; P = 0.015) and with more favorable outcome at 3 months (50% vs. 20%; P = 0.023). In multivariate analysis, successful reperfusion was associated with an adjusted odds ratio (95% confidence intervals) of 0.35 (0.10-1.12) for MMI and 2.77 (0.84-10.43) for 3-month favorable outcome occurrence.
CONCLUSIONS
Early successful reperfusion performed in patients with AIS with clinical and imaging predictors of MMI was associated with decreased MMI occurrence. Reperfusion status might be considered in evaluating the need for craniectomy in patients with early predictors of MMI.

Identifiants

pubmed: 32431009
doi: 10.1111/ene.14330
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1988-1995

Informations de copyright

© 2020 European Academy of Neurology.

Références

Thomalla G, Hartmann F, Juettler E, et al. Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: a prospective multicenter observational study. Ann Neurol 2010; 68: 435-445.
Ong CJ, Gluckstein J, Laurido-Soto O, Yan Y, Dhar R, Lee JM. Enhanced detection of Edema in Malignant Anterior Circulation Stroke (EDEMA) score. Stroke 2017; 48: 1969-1972.
Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015; 372: 2285-2295.
Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6: 215-222.
Wijdicks EFM, Sheth KN, Carter BS, et al. Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 1222-1238.
Kurland DB, Khaladj-Ghom A, Stokum JA, et al. Complications associated with decompressive craniectomy: a systematic review. Neurocrit Care 2015; 23: 292-304.
Turc G, Bhogal P, Fischer U, et al. European Stroke Organisation (ESO) - European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE). Eur Stroke J 2019; 4: 6-12.
Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2018; 49: 46-110.
Panni P, Gory B, Xie Y, et al. Acute stroke with large ischemic core treated by thrombectomy. Stroke 2019; 50: 1164-1171.
Nezu T, Koga M, Kimura K, et al. Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA registry. Neurology 2010; 75: 555-561.
Schröder J, Cheng B, Ebinger M, et al. Validity of acute stroke lesion volume estimation by diffusion-weighted imaging - Alberta stroke program early computed tomographic score depends on lesion location in 496 patients with middle cerebral artery stroke. Stroke 2014; 45: 3583-3588.
Wu S, Yuan R, Wang Y, et al. Early prediction of malignant brain edema after ischemic stroke. Stroke 2018; 49: 2918-2927.
Rumalla K, Ottenhausen M, Kan P, Burkhardt J-K. Recent nationwide impact of mechanical thrombectomy on decompressive hemicraniectomy for acute ischemic stroke. Stroke 2019; 50: 2133-2139.
Campbell BCV, Majoie CBLM, Albers GW, et al. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data. Lancet Neurol 2019; 18: 46-55.
Broocks G, Hanning U, Flottmann F, et al. Clinical benefit of thrombectomy in stroke patients with low ASPECTS is mediated by oedema reduction. Brain 2019; 142: 1399-1407.
Yoshimoto T, Inoue M, Yamagami H, et al. Use of diffusion-weighted imaging-alberta stroke program early computed tomography score (DWI-ASPECTS) and ischemic core volume to determine the malignant profile in acute stroke. J Am Heart Assoc 2019; 8: e012558.

Auteurs

C Sabben (C)

Department of Neurology, Rothschild Foundation Hospital, Paris.

J P Desilles (JP)

Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris.
Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Paris, Paris.

F Charbonneau (F)

Department of Neuroradiology, Rothschild Foundation Hospital, Paris.

J Savatovsky (J)

Department of Neuroradiology, Rothschild Foundation Hospital, Paris.

E Morvan (E)

Department of Neurology, Rothschild Foundation Hospital, Paris.

A Obadia (A)

Department of Neurology, Rothschild Foundation Hospital, Paris.

I Raynouard (I)

Department of Neurology, Rothschild Foundation Hospital, Paris.

F Fela (F)

Department of Neurology, Rothschild Foundation Hospital, Paris.

S Escalard (S)

Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris.

H Redjem (H)

Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris.

S Smajda (S)

Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris.

G Ciccio (G)

Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris.

R Blanc (R)

Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris.
Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Paris, Paris.

R Fahed (R)

Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris.

C Le Guerinel (C)

Department of Neurosurgery, Rothschild Foundation Hospital, Paris.

N Engrand (N)

Neuro Intensive Care Unit, Rothschild Foundation Hospital, Paris.

M Ben Maacha (M)

Research and Biostatistics Unit, Rothschild Foundation Hospital, Paris.

J Labreuche (J)

ULR 2694 - METRICS: Évaluation des technologies de santé et des pratiques médicales, CHU Lille, Université de Lille, Lille, France.

M Mazighi (M)

Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris.
Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Paris, Paris.

M Piotin (M)

Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris.
Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Paris, Paris.

M Obadia (M)

Department of Neurology, Rothschild Foundation Hospital, Paris.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH